Holen Sie sich die Stockscreener-App
2.14
2.88%
0.06
Handel nachbörslich:
2.14
Finanzdaten der Spero Therapeutics Inc-Aktie (SPRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
141.56%
14.19
|
5.874 | 15.04 | 13.47 | 10.20 |
Operating Expenses
|
19.28%
16.63
|
20.61 | 36.77 | 32.06 | 29.26 |
| Benefits Costs and Expenses |
19.51%
15.89
|
19.74 | 116.54 | - | 28.06 |
| Costs And Expenses |
19.51%
15.89
|
19.74 | 31.97 | 32.06 | 28.06 |
| Operating Income/Loss |
83.41%
-2.444
|
-14.73 | -21.73 | -18.59 | -19.06 |
| Nonoperating Income/Loss |
13.99%
0.744
|
0.865 | 1.127 | 1.156 | 1.199 |
| Income/Loss From Continuing Operations Before Tax |
87.74%
-1.70
|
-13.87 | -101.50 | 13.47 | -17.86 |
| Income/Loss From Continuing Operations After Tax |
87.74%
-1.70
|
-13.87 | -20.89 | -17.15 | -17.86 |
|
Net Income/Loss
|
87.74%
-1.70
|
-13.87 | -20.89 | -17.15 | -17.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | -0.038 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | 0.038 |
| Basic Average Shares |
1.17%
56.03
|
55.38 | 0.1681 | 54.12 | 53.96 |
| Diluted Average Shares |
1.17%
56.03
|
55.38 | 0.1681 | 54.12 | 53.96 |
| Basic Earnings Per Share |
88.00%
-0.03
|
-0.25 | -0.38 | -0.32 | -0.33 |
| Diluted Earnings Per Share |
88.00%
-0.03
|
-0.25 | -0.38 | -0.32 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | -0.038 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):